Showing 121 - 140 of 222 results
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
The Australian Synchrotron has an on-site Guesthouse for users and AS guests.
Australia and Sri Lanks signs new partnership to fight chronic kidney disease.
After careful selection, three Australian science teachers are set to fly to Geneva today after winning positions on the International High School Teacher Programme at CERN.
Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it. Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.
A team of scientists led by Monash University and the University of Melbourne in association with the Peter Doherty Institute for Infection and Immunity have made progress in clarifying the molecular interactions that underpin how our adaptive immune cells recognise SARS CoV-2, which causes COVID-19.
An opportunity to take an unforgettable journey and explore ANSTO science virtually at the atomic scale for National #scienceweek
Monash University, University of Queensland and Australian National University researchers have used ANSTO’s Australian Synchrotron in their study of meteorites found on Earth that could be used in future to find evidence of life on the planet Mars.
View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.
Physicist and cancer research Dr Mitra Safavi-Naeini, Macromolecular crystallography beamline scientist Dr Eleanor Campbell and Engineering Support Workshop Manager Bianca Shepherd have been chosen by Science and Technology Australia as the next Superstars of STEM
This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.
High intensity X-ray beam provides insights into the activity of natural killer cells.
